Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
97 participants
OBSERVATIONAL
2024-09-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New Biomarkers for Predicting Systemic Complications in Obesity
NCT07260487
Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese Subjects
NCT05447351
The Effects of Weight Loss on Psoriatic Arthritis
NCT05393141
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167
Chronotype-adapted Diet and Weight Loss
NCT05941871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals with obesity
This cohort includes adult participants diagnosed with obesity (BMI ≥30 kg/m²). No control group is included.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals who are literate
* Individuals diagnosed with obesity
Exclusion Criteria
* Individuals with chronic infectious or inflammatory diseases
* Individuals with cancer
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nurefşan KONYALIGİL ÖZTÜRK
Assist. Prof. Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nurefşan Konyalıgil Öztürk
Role: PRINCIPAL_INVESTIGATOR
Abant Izzet Baysal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bolu Abant İzzet Baysal University, Faculty of Health Sciences
Bolu, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIBU-BD-NKÖ-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.